Last $38.45 USD
Change Today -0.30 / -0.77%
Volume 92.3K
CMN On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

cantel medical corp (CMN) Snapshot

Open
$38.87
Previous Close
$38.75
Day High
$39.20
Day Low
$38.25
52 Week High
10/13/14 - $40.19
52 Week Low
02/3/14 - $29.60
Market Cap
1.6B
Average Volume 10 Days
187.7K
EPS TTM
$1.07
Shares Outstanding
41.5M
EX-Date
07/15/14
P/E TM
36.0x
Dividend
$0.09
Dividend Yield
0.23%
Current Stock Chart for CANTEL MEDICAL CORP (CMN)

Related News

No related news articles were found.

cantel medical corp (CMN) Related Businessweek News

No Related Businessweek News Found

cantel medical corp (CMN) Details

Cantel Medical Corp. provides infection prevention and control products and services in the healthcare market. Its Endoscopy segment offers medical device reprocessing systems, disinfectants, detergents, and other supplies used to disinfect flexible endoscopes; and disposable infection control products for cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures, as well as technical maintenance services on its products. The company’s Water Purification and Filtration segment provides water purification equipment and services, filtration and separation products, and disinfectants for the medical, pharmaceutical, biotech, beverage, and commercial industrial markets; and disinfectants, and decontamination services used in various applications for infection prevention and control. Its Healthcare Disposables segment offers single-use infection prevention and control healthcare products, including face masks, sterilization pouches, towels and bibs, tray covers, saliva ejectors, germicidal wipes, plastic cups, and disinfectants used principally in the dental market; and biological and chemical indicators for sterility assurance monitoring services in the acute-care, alternate-care, and dental markets. The company’s Dialysis segment provides medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates, and other supplies for renal dialysis. Its Specialty Packaging segment offers specialty packaging and thermal control products, as well as related compliance training for the transportation of infectious and biological specimens and thermally sensitive pharmaceutical, medical, and other products. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.

1,534 Employees
Last Reported Date: 09/29/14
Founded in 1963

cantel medical corp (CMN) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $550.0K
Chairman and Member - Office of the Chairman
Total Annual Compensation: $275.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $336.8K
Chief Operating Officer, Executive Vice Presi...
Total Annual Compensation: $302.6K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $336.8K
Compensation as of Fiscal Year 2013.

cantel medical corp (CMN) Key Developments

Cantel Medical Corp. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended July 31, 2014

Cantel Medical Corp. reported unaudited consolidated earnings results for the fourth quarter and full year ended July 31, 2014. For the fourth quarter, the company reported net sales of $131,377,000 against $113,973,000 a year ago. Income before interest and income taxes was $17,581,000 against $16,130,000 a year ago. Income before income taxes was $17,073,000 against $15,437,000 a year ago. Net income was $10,705,000 or $0.26 per diluted share against $10,213,000 or $0.25 per diluted share a year ago. EBITDA was $22,712,000 against $20,635,000 a year ago. EBITDAS was $24,143,000 against $21,562,000 a year ago. Cash flow provided by operations was $23.5 million in the quarter. Capital expenditures were $5.6 million in the quarter. For the year, the company reported net sales of $488,749,000 against $425,026,000 a year ago. Income before interest and income taxes was $70,928,000 against $63,188,000 a year ago. Income before income taxes was $68,611,000 against $60,354,000 a year ago. Net income was $43,265,000 or $1.04 per diluted share against $39,239,000 or $0.95 per diluted share a year ago. EBITDA was $90,315,000 against $80,635,000 a year ago. EBITDAS was $95,724,000 against $84,368,000 a year ago. Cash flow provided by operations was $64.3 million for the full year. Capital expenditures were $13.5 million for the full year. Adjusted EPS for the full year increased from $0.94 to $1.07, which represented year-over-year growth of 14% in fiscal year 2014. Net debt was $48.7 million as of July 31, 2014.

Cantel Medical Corp. to Report Q4, 2014 Results on Sep 29, 2014

Cantel Medical Corp. announced that they will report Q4, 2014 results at 9:00 AM, Eastern Standard Time on Sep 29, 2014

Cantel Medical Corp., Q4 2014 Earnings Call, Sep 29, 2014

Cantel Medical Corp., Q4 2014 Earnings Call, Sep 29, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CMN:US $38.45 USD -0.30

CMN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Getinge AB kr161.00 SEK +1.60
Hill-Rom Holdings Inc $43.62 USD +0.04
Mesa Laboratories Inc $69.96 USD +0.45
STERIS Corp $59.60 USD -0.75
Transcat Inc $9.47 USD 0.00
View Industry Companies
 

Industry Analysis

CMN

Industry Average

Valuation CMN Industry Range
Price/Earnings 36.9x
Price/Sales 3.3x
Price/Book 4.3x
Price/Cash Flow 36.8x
TEV/Sales 3.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CANTEL MEDICAL CORP, please visit www.cantelmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.